About Sh-Oligopeptide-1
Sh-Oligopeptide-1 (EGF), a synthetically produced peptide mimicking natural Epidermal Growth Factor, is utilized in topical cosmetic products for its potential skin rejuvenating properties. It stimulates cell growth and collagen production, aiding in wound healing and scar reduction. While generally safe for topical application, potential side effects include skin irritation and acne flare-ups. Theoretical concerns exist regarding its potential to stimulate tumor growth, but evidence supporting this in topical cosmetic use is limited. Dosage depends on the specific product and concentration.
Key Information
Compare All Forms
Compare different forms of Sh-Oligopeptide-1 by bioavailability, conversion rates, and active ingredient content:
| Form | Tier | Steps |
Sh-Oligopeptide-1 (mg) |
Bioavailability | Action |
|---|---|---|---|---|---|
|
Sh-Oligopeptide-1 (EGF)
Sh-Oligopeptide-1 (EGF) is a synthetic peptide that promotes... |
Tier 3 | 3 | — | Basic/low bioavailability form. Cheap raw material with poor absorption or high GI distress. Often poorly utilized by the body, requires 3+ conversion steps. | View → |
Scientific Evidence
Ricardo G. Azizkhan, Kenneth W. Sloan, and George K. Tompson. Topical Epidermal Growth Factor Accelerates Wound Healing. Journal of Burn Care & Rehabilitation, Vol. 13, No. 6, 1992, 625-630. R. Nanney. Epidermal growth factor. J Burn Care Rehabil. 1993 Jan-Feb;14(1):91-103. Pastar I, Stojadinovic O, Izadpanah A, et al. Epidermal growth factor and its receptors: structure, function, and role in wound healing. Adv Wound Care (New Rochelle). 2014;3(1):21-30.